Front Cell Dev Biol 2:67. https://doi.org/10.
3389/fcell.2014.00067
9. Kim D, Kim CH, Moon JI, Chung YG, Chang
MY, Han BS, Ko S, Yang E, Cha KY, Lanza R,
Kim KS (2009) Generation of human induced
pluripotent stem cells by direct delivery of
reprogramming proteins. Cell Stem Cell 4
(6):472–476.
https://doi.org/10.1016/j.
stem.2009.05.005
10. Zhang Y, Huang XR, Wei LH, Chung ACK, Yu
CM, Lan HY (2014) miR-29b as a therapeutic
agent for angiotensin II-induced cardiac fibrosis by targeting TGF-beta/Smad3 signaling.
Mol Ther 22(5):974–985
11. van Rooij E, Sutherland LB, Thatcher JE,
DiMaio JM, Naseem RH, Marshall WS, Hill
JA, Olson EN (2008) Dysregulation of microRNAs after myocardial infarction reveals a role
of miR-29 in cardiac fibrosis. P Natl Acad Sci
USA 105(35):13027–13032. https://doi.
org/10.1073/pnas.0805038105
12. Chang L, Bertani P, Gallego-Perez D, Yang Z,
Chen F, Chiang C, Malkoc V, Kuang T, Gao K,
Lee LJ, Lu W (2016) 3D nanochannel electroporation for high-throughput cell transfection
with high uniformity and dosage control.
Nanoscale 8(1):243–252. https://doi.org/
10.1039/c5nr03187g
13. Chang L, Gallego-Perez D, Zhao X, Bertani P,
Yang Z, Chiang CL, Malkoc V, Shi J, Sen CK,
Odonnell L, Yu J, Lu W, Lee LJ (2015)
Dielectrophoresis-assisted 3D nanoelectroporation for non-viral cell transfection in adoptive
immunotherapy.
Lab
Chip
15
(15):3147–3153. https://doi.org/10.1039/
c5lc00553a
14. Chang L, Gallego-Perez D, Chiang CL,
Bertani P, Kuang T, Sheng Y, Chen F,
Chen Z, Shi J, Yang H, Huang X, Malkoc V,
Lu W, Lee LJ (2016) Controllable large-scale
transfection of primary mammalian cardiomyocytes on a nanochannel array platform. Small
12(43):5971–5980.
https://doi.org/10.
1002/smll.201601465
3D Nanochannel Electroporation for Macromolecular Nucleotide Delivery
77
3389/fcell.2014.00067
9. Kim D, Kim CH, Moon JI, Chung YG, Chang
MY, Han BS, Ko S, Yang E, Cha KY, Lanza R,
Kim KS (2009) Generation of human induced
pluripotent stem cells by direct delivery of
reprogramming proteins. Cell Stem Cell 4
(6):472–476.
https://doi.org/10.1016/j.
stem.2009.05.005
10. Zhang Y, Huang XR, Wei LH, Chung ACK, Yu
CM, Lan HY (2014) miR-29b as a therapeutic
agent for angiotensin II-induced cardiac fibrosis by targeting TGF-beta/Smad3 signaling.
Mol Ther 22(5):974–985
11. van Rooij E, Sutherland LB, Thatcher JE,
DiMaio JM, Naseem RH, Marshall WS, Hill
JA, Olson EN (2008) Dysregulation of microRNAs after myocardial infarction reveals a role
of miR-29 in cardiac fibrosis. P Natl Acad Sci
USA 105(35):13027–13032. https://doi.
org/10.1073/pnas.0805038105
12. Chang L, Bertani P, Gallego-Perez D, Yang Z,
Chen F, Chiang C, Malkoc V, Kuang T, Gao K,
Lee LJ, Lu W (2016) 3D nanochannel electroporation for high-throughput cell transfection
with high uniformity and dosage control.
Nanoscale 8(1):243–252. https://doi.org/
10.1039/c5nr03187g
13. Chang L, Gallego-Perez D, Zhao X, Bertani P,
Yang Z, Chiang CL, Malkoc V, Shi J, Sen CK,
Odonnell L, Yu J, Lu W, Lee LJ (2015)
Dielectrophoresis-assisted 3D nanoelectroporation for non-viral cell transfection in adoptive
immunotherapy.
Lab
Chip
15
(15):3147–3153. https://doi.org/10.1039/
c5lc00553a
14. Chang L, Gallego-Perez D, Chiang CL,
Bertani P, Kuang T, Sheng Y, Chen F,
Chen Z, Shi J, Yang H, Huang X, Malkoc V,
Lu W, Lee LJ (2016) Controllable large-scale
transfection of primary mammalian cardiomyocytes on a nanochannel array platform. Small
12(43):5971–5980.
https://doi.org/10.
1002/smll.201601465
3D Nanochannel Electroporation for Macromolecular Nucleotide Delivery
77
